Cite

HARVARD Citation

    Issa, M. et al. (2022). Risk factors and predictors of immune-related adverse events: implications for patients with non-small cell lung cancer. Expert review of anticancer therapy. 22 (8), pp. 861-874. [Online]. 
  
Back to record